| 
|  |  |  Patients Who Are DES Sons
 
  |  |  |  
|  |  |  
 |  |  |  
|  |  
 Genitourinary Abnormalities
 Few studies have been conducted on health risks for men exposed 
              to DES in utero (DES Sons). These have generally yielded mixed results. 
              An increased risk of epididymal cysts has been documented in DES 
              Sons in several studies (196,201,209,225,236). These demonstrated 
              that 21% of DES Sons had epididymal cysts, compared to 5% of unexposed 
              men. Risks of other genital abnormalities, including testicular 
              hypoplasia, cryptorchidism, and microphallus have been reported 
              to be more common among DES Sons in some studies, but not others 
              (206,236).Lack of Increased Risk of Infertility Data from a prospective, blinded, placebo-controlled study of prenatal 
              DES exposure confirmed no impairment in fertility in men exposed 
              to DES in utero (DES Sons) (2,236).Related Concerns The principle 
              issues limiting firm conclusions about effects of DES on men exposed 
              in utero (DES Sons) have been small sample size, lack of randomization, 
              and the relative youth of the study cohort. From a clinical standpoint, 
              the most important issue is that the median age of men in reported 
              DES cohort studies is less than 50. Thus it is possible that health 
              effects may be found that affect elderly DES Sons that are not currently 
              recognized. Significant bias is introduced into non-randomized studies because 
              men with genital abnormalities are more likely to investigate whether 
              they were exposed to DES, and thus be identified as DES Sons. Data 
              from a cohort of offspring of women randomized to DES or placebo 
              during pregnancy exist, but sample sizes are relatively small.Genital Abnormalities Increased 
              risk of epididymal cysts has been documented consistently in DES 
              Sons. Risks of other genital abnormalities (testicular hypoplasia, 
              cryptorchidism, microphallus) have been associated with DES exposure 
              in some studies, but not others (206,217,233,236). It is unlikely 
              that this issue will ever be definitively resolved.Testicular Cancer Some case control 
              studies have suggested an increased risk of testicular cancer in 
              DES Sons, others have not. A prospective randomized study found 
              a trend to increased levels of testicular cancer compared to a control 
              group that was not statistically significant (231). Based on animal 
              studies, it is possible that significant cancer risks will be identified 
              as men age.Rete Testis and Prostatic Utricular Cancer Studies of mice exposed prenatally to DES have demonstrated an 
              increased incidence of tumors of the rete testes and metaplastic, 
              dysplastic, and neoplastic changes in the Prostatic utricle (219,220,221,223,224,225). 
              These organs develop from the same embryonic tissue (the Müllerian 
              duct) as the vagina, the site of known increased cancer risk in 
              DES Daughters. Cancers develop in older DES-exposed mice, correlating 
              to old age in humans. Although such tumors have not been demonstrated 
              to occur more frequently in DES Sons, the possibility remains that 
              they will be detected as the cohort ages. For a complete list of the numbered citations 
              on this page see DES References. Back to Top |